These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes. Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179 [TBL] [Abstract][Full Text] [Related]
23. Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups. Leo JM; Kalloger SE; Peixoto RD; Gale NS; Webber DL; Owen DA; Renouf D; Schaeffer DF J Clin Pathol; 2016 May; 69(5):431-9. PubMed ID: 26500334 [TBL] [Abstract][Full Text] [Related]
24. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis. Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047 [TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression. Gundlach JP; Hauser C; Schlegel FM; Willms A; Halske C; Röder C; Krüger S; Röcken C; Becker T; Kalthoff H; Trauzold A J Cancer Res Clin Oncol; 2021 Nov; 147(11):3313-3324. PubMed ID: 34302528 [TBL] [Abstract][Full Text] [Related]
26. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420 [TBL] [Abstract][Full Text] [Related]
27. HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Hristov AC; Cope L; Reyes MD; Singh M; Iacobuzio-Donahue C; Maitra A; Resar LM Mod Pathol; 2009 Jan; 22(1):43-9. PubMed ID: 18843278 [TBL] [Abstract][Full Text] [Related]
28. The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer. Hu H; Hang JJ; Han T; Zhuo M; Jiao F; Wang LW Tumour Biol; 2016 Jul; 37(7):8657-64. PubMed ID: 26738860 [TBL] [Abstract][Full Text] [Related]
29. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma. Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693 [TBL] [Abstract][Full Text] [Related]
30. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment. Wong CW; Han HW; Tien YW; Hsu SH Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136 [TBL] [Abstract][Full Text] [Related]
32. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma. Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532 [TBL] [Abstract][Full Text] [Related]
33. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma. Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886 [TBL] [Abstract][Full Text] [Related]
34. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer. Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743 [TBL] [Abstract][Full Text] [Related]
35. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774 [TBL] [Abstract][Full Text] [Related]
36. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Abe N; Watanabe T; Suzuki Y; Matsumoto N; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Atomi Y Br J Cancer; 2003 Dec; 89(11):2104-9. PubMed ID: 14647145 [TBL] [Abstract][Full Text] [Related]
37. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993 [TBL] [Abstract][Full Text] [Related]
38. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function. Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450 [TBL] [Abstract][Full Text] [Related]
39. Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Drifka CR; Loeffler AG; Mathewson K; Keikhosravi A; Eickhoff JC; Liu Y; Weber SM; Kao WJ; Eliceiri KW Oncotarget; 2016 Nov; 7(46):76197-76213. PubMed ID: 27776346 [TBL] [Abstract][Full Text] [Related]
40. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]